The purchase includes the manufacturing process of four ELISA kits, two of which are in vitro diagnostic products for specialty diagnostics and disease monitoring.

NEW YORK — ABL Diagnostics said on Wednesday that it has signed an agreement for the distribution of its infectious disease molecular assays in India with Genient Tech Private.

Of the 30 companies, three saw their stock prices increase, 26 saw their share prices decline, and one company's share price remained virtually flat month over month.

The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.

The firm said that it has received approval for a test that combines the Allsheng-developed Auto-Pure 2400 liquid handling platform with Revvity's T-SPOT.TB test.

The aggregate repurchase authorization program now totals $200 million, which the firm will fund with cash and cash equivalents.

Last week, readers were most interested in a story about Roche ramping up the commercialization of its sample self-collection devices for HPV.

The firm raised the money last week in a public offering of 14,375,000 common shares, and it will use the money for working capital and general corporate purposes.

NEW YORK – Cancer Research Horizons, a translational subsidiary of Cancer Research UK, announced on Monday that it has awarded £230,000 ($302,582) to researchers at the University of Birmingham to ...

The all-stock deal combines Longevity's human longevity and health aging products with 20/20s lab tests including its OneTest multi-cancer early detection assay.